ArticleBiomedicines2023

MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype.

Tiantian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.